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It is well established that the transcription rate of the rRNA gene is closely 
associated with profound alterations in the cell growth rate.  Regulation of the rRNA 
gene transcription is likely to be dependent on the dynamic conversion of the chromatin 
structure.  Previously, we identified B23/nucleophosmin, a multi-functional nucleolar 
phosphoprotein, as a component of Template Activating Factor-III that remodels the 
chromatin-like structure of the adenovirus genome complexed with viral basic proteins.  
It is also shown that B23 has the histone chaperone activity.  Here, we examined the 
effect of B23 on the rRNA gene transcription.  B23 was found to be associated with the 
rRNA gene chromatin.  siRNA-mediated down-regulation of the B23 expression level 
resulted in reduction of the transcription rate of the rRNA gene.  We constructed a B23 
mutant termed B23ΔC, which lacks the domain essential for the histone chaperone 
activity and inhibited the histone binding activity of B23 in a dominant-negative manner.  
Expression of B23ΔC decreased the rRNA gene transcription and the rate of cell 
proliferation.  These suggest that B23 is involved in the transcription regulation of the 
rRNA gene as a nucleolar histone chaperone. 
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To ensure the protein synthesis level, growing cells require continuous ribosome 
supply by synthesis of ribosomal proteins and ribosomal RNA (rRNA).  The transcription 
rate of the rRNA gene by RNA polymerase I (Pol I) is closely correlated with the cell growth 
rate (19).  In eukaryotic cells, rRNA genes are found in multiple tandem-arrayed copies in 
the nucleolus, known as nucleolar organizer region (NOR).  The tandem rRNA gene repeats 
exist in two distinct types of chromatin, an ‘open’ one permissive for transcription and a 
‘closed’ one under the transcriptionally repressive state (6).  Several epigenetic 
characteristics including differential DNA methylation and specific histone modification also 
differ between potentially active and inactive rRNA genes (18), so that the epigenetic control 
mechanism is important for the transcription regulation of the rRNA gene.  For instance, it is 
reported that the nucleolar remodeling complex (NoRC) is a member of ATP-dependent 
chromatin remodeling factors, and consists of ATPase Snf2h and TIP5 localized in nucleoli 
(54).  It is suggested that NoRC plays an active role in nucleosome dynamics at the rRNA 
gene promoter in an ATP-dependent manner, and specific nucleosome positions determine the 
transcriptional readout of the rRNA gene (33).  NoRC interacts with histone deacetylases, 
histone methyltransferases, and DNA methyltransferases, and targets these enzymatic 
activities to the rRNA gene promoter to form heterochromatin (18).  In addition to histone 
modification enzymes and ATP-dependent chromatin remodeling factors, it is shown that 
nucleolin, one of histone chaperones localized in the nucleolus, enhances the activity of 
chromatin remodeling machineries, SWI/SNF and ACF, and promotes the transcription from 
nucleosomal template in vitro (1).  Experiments using siRNA for nucleolin showed that 
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 nucleolin is involved in the transcription of the rRNA gene in vivo.  Moreover, chromatin 
immunoprecipitation (ChIP) experiments showed that nucleolin is associated with the 
chromatin around the 18S rRNA gene (48). 
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 To identify a factor involved in structural change of chromatin, we have taken 
advantage of the adenovirus (Ad) DNA complexed with viral basic core proteins, called Ad 
core (28, 36, 44).  The viral genome is packed around core protein VII hexamer, and a unit 
of the viral nucleosome is bridged by core protein V (8, 55).  Because of the chromatin-like 
structure of Ad core, the access to the viral genome of the factors required for the replication 
and transcription is restricted.  Using a cell-free DNA replication system using Ad core as a 
template, we have identified three host factors termed Template Activating Factor (TAF)-I, 
TAF-II, and TAF-III.  TAF-I and TAF-II are found to be identical to the leukemia-associated 
gene product SET (58) and Nucleosome Assembly Protein-1 (NAP-1) (28), respectively.  
The major component of TAF-III is B23/nucleophosmin, a nucleolar phosphoprotein (44).  
Recombinant B23 induces the structural alteration of Ad core, thereby stimulating the Ad core 
DNA replication (44, 49).  TAF-I and NAP-1 bind to core histones directly and transfers 
them to naked DNA (25, 35).  TAF-I is not only involved in the replication and transcription 
of Ad core (20, 21, 37), but also suggested to be involved in regulation of chromatin structure 
in eukaryotic cells (14, 27).  In addition, TAF-I promotes vitamin D3 receptor- and 
Gal4-VP16-dependent transcription from chromatin template in vitro (14), and stimulates the 
transcription of a sub-set of genes in HeLa cells in a histone acetylation-independent manner 
(27).  TAF-I also plays an important role in transcription regulated by transcription factors 
such as MLL (mixed lineage leukemia), Sp1, and KLF5 (39, 53, 56). 
We have demonstrated that B23 binds to core histones directly and transfers them to 
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 naked DNA (45) as do TAF-I (35) and NAP-1 (25), and the acidic regions of B23 are 
important for its activity (45).  The amino-terminal domain of B23 shows significant 
similarity to nucleoplasmin, which is the first identified histone chaperone (32).  Recently, it 
is indicated that B23 is acetylated, and acetylated B23 has the enhanced histone chaperone 
activity and stimulates in vitro transcription from chromatin templates by RNA polymerase II 
in the presence of p300 (57).  The crystal structure of the N-terminal domain of NO38, a 
Xenopus homolog of human B23, indicates that NO38 forms a pentamer and each pentamer 
further assembles into a decamer as does nucleoplasmin (10, 41).  These studies suggest that 
oligomer formation of nucleoplasmin family proteins may be important for their histone 
chaperone activity.  Based on its nucleolar localization and biochemical properties, it is 
reasonably assumed that B23 is involved in regulation of the chromatin structure around the 
rRNA gene through its histone chaperone activity. 
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B23 is also termed as nucleophosmin, numatrin, or NPM1, and was initially 
identified as an abundant nucleolar phosphoprotein (47).  These properties are similar to 
those of nucleolin, alternatively termed C23 (47).  The expression level of B23 is 
up-regulated in association with growth factor-induced mitogenesis (12).  A positive 
correlation has been reported among the quantity of B23 and nucleolin, the rate of Pol I 
transcription, and the cell proliferation rate (7).  There exist two subtypes of B23 termed 
B23.1 and B23.2, the latter of which lacks the carboxyl-terminal region present in B23.1 (4).  
B23 is a multi-functional protein: It is suggested that B23 is involved in rRNA maturation 
through its nucleic acid binding and ribonuclease activities (9, 22).  B23 is shown to play a 
critical role in centrosome duplication (43).  Inactivation of B23 in mouse embryonic 
fibroblasts (MEFs) leads to unrestricted centrosome duplication and severe genomic 
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 instability in addition to reduction of the cell proliferation rate (17).  B23 is also involved in 
regulation of the cell cycle progression.  In normal cells, B23 targets ARF in the nucleolus 
by binding to ARF through the Mdm2 binding domain of ARF, thus allowing Mdm2 to 
interact with p53 for degradation of p53.  Upon exposure to genotoxic stresses, the 
interaction between B23 and ARF is abrogated, so that the stability of p53 is increased (2, 5, 
29).  These indicate that B23 controls the cell cycle through the p53 pathway. 
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Here, we examined the effect of the histone chaperone activity of B23 on the rRNA 
gene transcription.  We showed that down-regulation of B23 by siRNA reduces the 
transcription rate of the rRNA gene.  Nucleolar chromatin immunoprecipitation analyses 
demonstrated that B23 binds to the chromatin around the rRNA gene promoter.  In order to 
characterize the function of B23 as a histone chaperone in the nucleolus, we constructed 
deletion mutants lacking the histone binding activity.  B23ΔC, devoid of the functional 
acidic regions, formed a hetero-oligomer with B23 and inhibited the histone binding activity 
in a dominant-negative manner.  Over-expression of B23ΔC reduced the transcription level 
from the rRNA gene.  These results altogether suggest that B23 regulates the transcription 
from the rRNA gene chromatin as a nucleolar histone chaperone. 
 
6 
 MATERIALS AND METHODS 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
 
Cell culture and transfection 
293T and p53-/- MEF cells were cultured at 37ºC in DMEM supplemented with 10% 
fetal bovine serum (FBS).  HeLa cells were cultured at 37ºC in MEM supplemented with 
10% FBS.  Transient transfection was performed using TransIT-293 (Mirus) for 293T cells, 
TransIT-LT1 (Mirus) for p53-/- MEF, and GeneJuice (Novagen) for HeLa cells.  HeLa cells 
were transfected with the siRNA using Lipofectamine 2000 (Invitrogen). 
 
Preparation of plasmids 
pCHA-B23.1 was prepared as previously described (44). To generate pCHA-B23ΔC, 
a fragment of B23ΔC3 cDNA was prepared by digestion of pET14b-hB23ΔC3 (44) with Nde 
I and BamH I.  The fragment was then cloned in-frame to BstE II- and Bgl II-digested pCHA 
(44).  To generate pUC119-HurDNA, the human rRNA gene (-192~+703 relative to the 
transcription start site (+1)) was amplified by PCR using genomic DNA purified from HeLa 
cells as template.  To amplify the human rRNA gene, two oligonucleotides, 
5’-CGCGGATCCTGTCCTTGGGTTGACCAGAG-3’ and 
5’-CCGGAATTCGCAAGTCGACAACCACTGGA-3’, were used as primers.  The 
amplified human rRNA gene fragment was cloned into the BamH I- and EcoR I-digested 
pUC119.  For expression of Flag-tagged B23.1, B23.1 cDNA attached by the Flag-tag was 
excised from pBS-Flag-B23.1 (46) by BamH I, and subcloned into BamH I-digested pcDNA3 
vector (CLONTECH).  To create pCAGGS-Flag-B23.1, a DNA fragment encoding 
Flag-tagged B23.1 was excised from pBS-Flag-B23.1 by BamH I, and subcloned into Bgl 
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 II-digested pCAGGS vector.  To generate pET-14b-B23ΔA1, a DNA fragment of B23ΔA1 
was amplified by two-step PCR using four oligonucleotides, 
5’-GCTAGTTATTGCTCAGCGG-3’ and 5’-AGTAGCTGTGGTGAAACTCTTAAGTATA-3’, 
and 5’-TAATACGACTCACTATAGG-3’ and 
5’-AGAGTTTCACCACAGCTACTAAGTGCTG-3’, and pET-14b-B23.1 as a template, and 
cloned into the Nde I and BamH I-digested pET-14b.  To generate pET-14b-B23ΔA, a DNA 
fragment of B23ΔA was amplified by two-step PCR using four oligonucleotides, 
5’-GCTAGTTATTGCTCAGCGG-3’ and 
5’-ACTTGCTGCTAAAGCGCCAGTGAAGAAA-3’, and 
5’-TAATACGACTCACTATAGG-3’ and 5’-CTGGCGCTTTAGCAGCAAGTTTTACTTT-3’, 
and pET-14b-B23ΔA1 as a template, and cloned into the Nde I and BamH I-digested pET-14b.  
To generate pBS-Flag-B23ΔA, a DNA fragment of B23ΔA was prepared by digestion of 
pET-14b-B23ΔA with Nde I and Hind III and cloned into the Nde I and Hind III-digested 
pBS-Flag.  To generate pCAGGS-Flag- B23ΔA, a DNA fragment of Flag-B23ΔA was 
prepared by digestion of pBS-Flag-B23ΔA with BamH I and cloned into Bgl II-digested 
pCAGGS. 
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Antibodies 
Antibodies used in this study were as follows: Mouse monoclonal antibody for B23 
(Zymed) recognizes both endogenous B23.1 and B23ΔA proteins, but not B23ΔC protein.  
For immunofluorescence assays of B23, goat polyclonal anti-B23 antibody (Santa Cruz 
Biotechnology) was used; for histone H3, rabbit polyclonal antibody (Abcam); for acetylated 
histone H3, rabbit polyclonal antibody (Upstate); for TBP, rabbit polyclonal antibody (Santa 
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 Cruz Biotechnology); for UBF, rabbit polyclonal antibody (F-9, Santa Cruz Biotechnology); 
for nucleolin, mouse monoclonal antibody (Santa Cruz Biotechnology); for fibrillarin, rabbit 
polyclonal antibody (Santa Cruz Biotechnology); for HA-tag, rabbit polyclonal antibody 
(MBL) or rat monoclonal antibody (3F10, Roche); for Flag-tag, mouse monoclonal antibody 
(M2, Sigma); for His-tag, mouse monoclonal antibody (Sigma); for β-actin, mouse 
monoclonal antibody (Sigma). 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
 
Immunoprecipitation 
Cells were lysed and sonicated in buffer A (50 mM Tris-HCl [pH 7.4], 0.1% NP-40) 
containing 100 mM NaCl.  Antibodies, BSA (1 mg/ml at the final concentration), and 
protein A-Sepharose beads (GE Healthcare) were added to the lysate, and incubated at 4ºC for 
2-4 h.  The beads were washed extensively with buffer A containing 300 mM NaCl, and 
proteins bound to the beads were eluted with an SDS sample buffer.  Proteins were separated 
through 10% SDS-PAGE and detected by immunoblotting using anti-HA, anti-B23, anti-Flag, 
or anti-histone H3 antibodies. 
 
Pulse labeling of B23 
293T cells (1 x 105) were suspended in 200 μl per assay of methionine free-MEM 
(Invitrogen).  Met 35S label (American Radiolabeled Chemicals) containing [35S]methionine 
(20 μCi per assay) was added, and cells were incubated at 37ºC for 1 h.  Cell lysates were 
prepared and B23 was immuno-purified using anti-B23 antibody.  Labeled proteins were 
separated by a 10% SDS-PAGE and visualized by autoradiography. 
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 B23 Stealth RNAi select containing siB23-A (NPM1-HSS143152), siB23-B 
(NPM1-HSS143153), and siB23-C (NPM1-HSS143154), and control Stealth RNAi Negative 
control (Cat. 12935-200, Invitrogen) were introduced into HeLa cells with Lipofectamine 
2000 (Invitrogen) according to the manufacturer’s protocol.  At 24 h post transfection, the 
medium was replaced, and cells were harvested at 72 h post siRNA introduction.  Proteins in 
HeLa cell lysates was separated by a 10% SDS-PAGE and detected by immunoblotting. 
Total RNA was prepared by RNeasy mini kit (Qiagen) and RNase-free DNase I 
(Qiagen).  For analysis of 45S pre-rRNA, total RNA was subjected to reverse transcription 
with a primer, 5’-CCATAACGGAGGCAGAGACA-3’, corresponding to the 5’ external 
transcribed spacer (ETS) of the rRNA gene, and the synthesized cDNA was used for 
quantitative PCR using FullVelocity SYBR Green Q-PCR Master Mix (STRATAGENE) in 
the presence of a primer set, 5’-GCCTTCTCTAGCGATCTGAGAG-3’ and 
5’-CCATAACGGAGGCAGAGACA-3’ corresponding to the 5’ external transcribed spacer of 
rRNA as described (48). For analysis of β-actin, total RNA was subjected to reverse 
transcription with oligo dT as a primer, and the synthesized cDNA was used as a template for 
PCR amplification for β-actin in the presence of a primer set, 
ATGGGTCAGAAGGATTCCTATGT-3’ and 5’-GGTCATCTTCTCGCGGTT-3’. 
For immunofluorescence, HeLa cells transfected with siRNA on glass slides were 
permeablized with 0.1% Triton X-100, and then subjected to cross-linking with 4% 
formaldehyde.  Then, B23 was detected with goat anti-B23 polyclonal antibody.  DNA was 
stained with 4’,6-diamidino-2-phenylindole (DAPI). 
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Preparation of nucleoli and nucleolar ChIP were carried out according to the 
protocol described previously (42).  Nucleoli were prepared from 6 x 106 cells pre-fixed by 
formaldehyde (0.25% for 10 min at 37ºC).  Nucleolar ChIP assays were carried out 
according to the manual of the ChIP assay kit (Upstate).  Quantitative PCR was carried out 
using FullVelocity SYBR Green QPCR Master Mix (STRATAGENE).  PCR reactions were 
carried out using primer sets corresponding to the rRNA gene indicated in Table 1. 
 
Run-on assay 
Transcriptionally active nuclei were prepared from 293T cells (1 X 106) by 
treatment with NP-40 buffer (10 mM Tris-HCl [pH7.9], 10 mM NaCl, 3 mM MgCl2, and 
0.1% NP-40) and resuspended in 30 μl of glycerol stock buffer (10 mM Tris-HCl [pH7.9], 0.1 
mM EDTA, 3 mM MgCl2, and 40% glycerol), and stored at –80ºC until use.  The isolated 
nuclei (30 μl) were mixed with 30 μl of a reaction buffer containing 10 mM Tris-HCl [pH7.9], 
300 mM KCl, 5 mM MgCl2, 0.5 mM each A, C, UTP, 50 μCi [α-32P]GTP (~400 Ci/mmol) 
(Amersham), and 40 units RNase inhibitor (TOYOBO), and incubated at 30ºC for 30 min.  
Genomic DNA was digested with 200 units of DNase I at 30ºC for 10 min followed by 
incubation with 100 μg proteinase K at 42ºC for 30 min.  RNA was extracted with 
phenol/chloroform, and the newly transcribed RNA was monitored by hybridization with 1 μg 
of denatured pUC119-HurDNA or pUC119 immobilized on Hybond-N+ membranes.  The 
intensity of hybridization dots was measured using the Image Gauge Program (Fuji-film). 
 
In vitro histone binding assay 
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 His-tagged B23.1, B23ΔA, and B23ΔC proteins were prepared as described (44).  
His-B23.1 and His-B23ΔC proteins were mixed at appropriate ratios and precipitated by cold 
acetone.  The precipitated proteins were denatured in a guanidine buffer (50 mM 
HEPES-NaOH [pH7.9], 150 mM NaCl, 0.1 mM EDTA, 0.5 mM DTT, 0.1% NP-40, and 6 M 
Guanidine-HCl) at room temperature for 15 min and renatured by dialysis against buffer 
containing 20 mM HEPES-NaOH [pH7.9], 50 mM NaCl, 0.5 mM EDTA, 1 mM DTT, 0.1 
mM PMSF, and 10% Glycerol.  Renatured B23 proteins were mixed and incubated at 4ºC 
for 30 min with core histones purified from HeLa cells in 50 μl of 50 mM Tris-HCl [pH7.9], 
270 mM NaCl, 1 mM MgCl2, 0.1 mM PMSF, 0.1 mg/ml BSA, and 0.1% NP-40.  
Immunoprecipitation was carried out using anti-His or anti-B23 antibodies.  Precipitated 
proteins were analyzed by a 12.5% SDS-PAGE and visualized by silver staining and 
immunoblotting using anti-His and anti-histone H3 antibodies. 
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Nucleosome assembly assay 
 Supercoiled plasmid DNA (pCAGGS) was relaxed by incubation with 
topoisomerase I (TaKaRa) at 37ºC for 30 min.  The supercoiling assay was performed 
essentially as described (24).
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Relationship between the cell growth rate and the rRNA gene transcription level 
 The relationship among the cell growth rate, the transcription rate of the rRNA gene, 
and the expression level of B23 was examined using 293T cells maintained in the presence of 
either 1% or 10% of serum.  The expression level of B23 was examined by pulse-labeling 
with [35S]methionine.  The pulse-labeled B23 was immunoprecipitated with an anti-B23 
antibody and analyzed through a 10% SDS-PAGE followed by autoradiography.  The 
expression level of B23 was approximately four fold higher in the presence of 10% serum 
than in the presence of 1% serum at 48 h (Fig. 1A, lanes 3 and 4).  This result is consistent 
with the report that the expression of B23 is associated with growth factor-induced 
mitogenesis in Swiss 3T3 cells (12).  The expression level of nucleolus-related proteins was 
examined in cells maintained in the presence of 1% or 10% serum by immunoblotting using 
anti-UBF, anti-nucleolin, anti-fibrillarin, and anti-β-actin antibodies.  The protein expression 
level of UBF and nucleolin, both of which are known to be involved in the transcription of the 
rRNA gene, was reduced in the presence of 1% serum compared with that of 10% serum at 48 
h (Fig. 1B) as was the case for B23.  On the other hand, the expression level of fibrillarin 
involved in the processing of pre-rRNA and β-actin was almost equal between cells 
maintained in 1% and 10% serum (Fig. 1B).  The reduction level of mRNAs of UBF, 
nucleolin, TIF-IA, fibrillarin, and β-actin by low serum was virtually equal (see Fig. S1 in the 
supplemental material).  These results suggest that the transcription by RNA polymerase II is 
evenly affected by serum concentrations and the expression level of proteins involved in the 
rRNA gene transcription is coordinately regulated at the level of translation and/or protein 
13 
 degradation.  In parallel, the transcription rate of the rRNA gene was monitored by run-on 
assays.  The transcription level of the rRNA gene in cells maintained in the presence of 1% 
serum was lower by 0.7 fold than that in the presence of 10% serum (Fig. 1C).  The amount 
of pre-rRNA was also monitored by quantitative RT-PCR using a primer set corresponding to 
the 5’ external transcribed spacer (5’ ETS) of pre-rRNA (48) as described in Materials and 
Methods in detail.  The results were normalized as a ratio to that of β-actin.  The amount of 
pre-rRNA in cells maintained in the presence of 1% serum was lower by 0.6 fold than that in 
the presence of 10% serum (Fig. 1D).  The number of rRNA transcripts in cells under the 
growing condition is about 80% of the total cellular RNA quantity (40).  Thus, this 
difference in the rRNA gene transcription rate between cells in 1% and 10% serum affect the 
cellular metabolism significantly.  These results indicate that the rate of the rRNA gene 
transcription and the cell growth are positively correlated with the expression level of genes 
involved in the rRNA gene transcription including B23.  Hereafter, we focused functional 
studies on B23. 
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Knock-down of B23 decreases the transcription rate of the rRNA gene 
 To investigate the role of B23.1 in transcription of the rRNA gene, knock-down 
(KD) of the B23.1 expression was performed using short interfering RNA (siRNA) specific 
for B23.1, siB23-A, -B, and -C.  Introduction of the siRNA decreased the protein level of 
B23.1, but not β-actin, whereas a control siRNA had no effect (Fig. 2A).  The expression 
level of other nucleolus-related genes was also examined in cells treated with siB23-C, and 
siB23-C was found to have no effect on the expression of other nucleolus-related genes (Fig. 
2B).  Therefore, we could examine the function of B23.1 without other possible indirect 
14 
 effect of siB23-C.  KD of B23.1 was also confirmed in nucleoli of HeLa cells by 
immunofluoresence using anti-B23 antibody (Fig. 2C).  The amount of pre-rRNA in HeLa 
cells transfected with siB23 or control siRNA was examined by quantitative RT-PCR using 5’ 
ETS-specific primers for the rRNA gene.  The amount of pre-rRNA was normalized as a 
ratio to that of β-actin mRNA.  KD of the B23 expression level resulted in decreased 
transcription of the rRNA gene (Fig. 2D, right panel).  The trancription level of the rRNA 
gene in cells treated by siB23-C was lower by 0.5 fold than that of control siRNA.  These 
results indicate that B23 plays an important role in transcription of the rRNA gene by Pol I. 
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B23 is associated with the chromatin around the rRNA gene 
The amino-terminal domain of B23 shows significant similarity to nucleoplasmin, 
which is the first identified histone chaperone (32).  B23 has been shown to bind with 
histones (45) and localized in nucleoli.  Thus, it is reasonably hypothesized that B23 binds to 
chromatin around the rRNA gene.  To examine this, we performed nucleolar chromatin 
immunoprecipitation (ChIP) as described in Materials and Methods.  Nucleoli isolated from 
HeLa cells cross-linked with formaldehyde were sonicated to release chromatin fragments.  
DNA purified from chromatin fragments ranged in size less than 1 Kbp (Fig. S3 in 
supplemental material).  Sonicated chromatin was subjected to immunoprecipitation with 
anti-Flag antibody as a negative control and anti-B23 antibody, followed by quantitative PCR 
using a primer set specific for the rRNA gene promoter.  The antibody against TBP was also 
used, since TBP is one of landmarks of the active promoter.  Figure 3A indicates that B23 as 
well as TBP is associated with the chromatin around the rRNA gene promoter.  Next, 
quantitative PCR was performed using primer sets corresponding to the entire rRNA gene 
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 (Table 1) and immunoprecipitated chromatin DNA as a template.  It is indicated that B23 
binds the overall rRNA gene unit, but is concentrated at the transcription initiation site and the 
region encoding 5.8S rRNA (Fig. 3B).  Binding of B23 at the region encoding 5.8S rRNA 
could correspond to the function of B23 for the processing of internal transcribed spacer 2 
(ITS2) of pre-rRNA (22, 26, 51).  The binding activity of B23 at the transcription initiation 
site was examined in cells maintained in the presence of 1% or 10% of serum.  The binding 
activity of B23 to the rRNA gene in cells maintained in the presence of 10% serum is higher 
than that in the presence of 1% (Fig. 3C).  Moreover, we examined the chromatin structure 
of the rRNA gene promoter region in cells treated with siB23-C.  The amount of B23 
associated with the rRNA gene promoter region was decreased in cells treated with siB23-C, 
while that of fibrillarin or transcription factors of the rRNA gene, that are TBP and UBF, were 
not influenced upon treatment with siB23-C (Fig. 3D, upper and middle panels).  In contrast, 
the amount of histone H3 associated with the rRNA gene increased upon treatment with 
siB23-C (Fig. 3D, lower panel).  The amount of histone H3 associated with the rRNA gene 
chromatin was 2 fold higher in cells treated with siB23-C than that of control siRNA.  
Histone distribution over the rRNA gene locus was examined (Fig. 3E, upper panel).  The 
amount of histone H3 associated with the rRNA gene in the cells treated with siB23-C was 
higher than that of control cells over the rRNA gene locus.  The ratio of the histone density 
on the rRNA gene in cells treated with siB23-C relative to that in control cells is plotted (Fig. 
3E, middle panel).  This plot shows that the histone density around the transcription start site 
and non-coding region between +15 Kbp and +20 Kbp relative to the transcription start site is 
increased more than other regions.  It is possible that the increase of the histone density on 
the promoter region may decrease the transcription efficiency of the rRNA gene, although it is 
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 presently unclear how the high histone density of the non-coding region affects the rRNA 
gene transcription.  These results suggest that B23 is involved in control of the histone 
density over the rRNA gene. 
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B23ΔC inhibits the histone binding activity of B23.1 in vitro 
To understand the function of B23 as a histone chaperone, we tried to prepare 
deletion mutants of B23.1 aiming construction of a dominant-negative type mutant to block 
the histone chaperone function of B23 specifically.  The acidic regions of B23 are crucial for 
both histone binding and histone chaperone activities (44, 45).  The crystal structure of the 
N-terminal domain of NO38, a Xenopus homolog of human B23, indicates that NO38 forms a 
pentamer and each pentamer further assembles into a decamer as does nucleoplasmin (10, 41).  
These studies suggest that oligomer formation of nucleoplasmin family proteins is important 
for their histone chaperone activity.  Thus, we hypothesized that a B23 protein containing the 
oligomeric domain but lacking domains responsible for its histone chaperone activity is to be 
a dominant-negative type protein.  To test this, B23 mutants termed B23ΔA and B23ΔC 
lacking either the acidic region or both the acidic and the carboxyl-terminal region, 
respectively, was prepared (Fig. 4A).  Recombinant hexa histidine-tagged (His-) B23.1, 
B23ΔA, and B23ΔC proteins were expressed in E. coli and purified (Fig. 4B). 
To examine the histone binding activity of B23 mutants, histone binding assays 
were carried out in vitro using recombinant B23 mutant proteins and core histones purified 
from HeLa cells.  B23 proteins and core histones were mixed and incubated, followed by 
immunoprecipitation with anti-His antibody and immunoblotting with anti-His and 
anti-histone H3 antibodies.  His-B23ΔC did not bind to core histones, whereas the histone 
17 
 binding activity of His-B23ΔA was essentially the same as that of wild type His-B23.1 (Fig. 
4C).  The fact that B23ΔA binds to histone H3 indicates that the other domain except for 
acidic domains is important for histone binding.  Nucleosome assembly activity of B23ΔA 
was examined using supercoiling assay (Fig. 4D).  His-B23.1 assembled nucleosomes in a 
dose-dependent manner, and His-B23ΔC did not as previously described (45).  Although 
His-B23ΔA bound with core histones, it could not transfer core histones to plasmid DNA (Fig. 
4D).  This result indicates that acidic domains of B23.1 are crucial for the histone chaperone 
activity. 
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We confirmed that B23ΔC does not have histone binding and nucleosome assembly 
activities (Figs. 4C and 4D).  Then, we examined whether B23ΔC is a dominant-negative 
type protein for B23.1.  When mixed directly, His-B23ΔC did not form a hetero-oligomer 
with His-B23.1 in vitro, suggesting that B23 forms a stable oligomer (data not shown).  
However, when a mixture of His-B23.1 and His-B23ΔC was subjected to the 
denature-renature protocol as described in Materials and Methods, two proteins were found to 
form a hetero-oligomer successfully.  The interaction between B23 oligomers and core 
histones was examined by immunoprecipitation using the anti-B23 antibody that can not 
recognize B23ΔC (data not shown).  Immunoprecipitated proteins were separated by a 
12.5% SDS-PAGE, followed by silver staining (Fig. 4E, left panel) and immunoblotting (Fig. 
4E, right panel) using anti-His antibody.  B23.1 formed a hetero-oligomer with His-B23ΔC 
(Fig. 4E, right panel, lanes 3 and 4).  B23.1 interacted efficiently with core histones (Fig. 4E, 
left panel, lane 2) as shown in Fig. 4C and a previous report (45).  However, the histone 
binding activity of B23.1 was decreased by oligomer formation with increasing amounts of 
His-B23ΔC (Fig. 4E, left panel, lanes 3 and 4).  The molar ratio between His-B23.1 and 
18 
 His-B23ΔC used here was 1:2.5 and 1:5 in lanes 3 and 4, respectively.  Since B23 was 
shown to form a pentamer, it is likely that a His-B23.1 pentamer including four His-B23ΔC 
molecules lost the histone binding activity completely.  We concluded that oligomer 
formation of B23 is critical for its histone binding activity and B23ΔC inhibits the histone 
binding activity of B23.1 in a dominant-negative manner. 
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B23ΔC inhibits the histone binding activity of B23.1 in vivo 
To use the B23 mutant proteins as tools for functional analyses of B23 in vivo, we 
examined whether B23 mutants inhibit the histone binding activity of B23.1.  First, we 
confirmed the expression of each B23 protein by immunoblotting using lysates of 293T cells 
transfected with plasmids encoding HA-B23.1, HA-B23ΔC, Flag-B23.1, or Flag-B23ΔA 
proteins (Fig. 5A).  To examine the histone binding activity of B23 mutants, 
immunoprecipitation with anti-HA and anti-Flag antibodies was performed using lysates 
prepared from 293T cells expressing HA-B23.1, HA-B23ΔC, Flag-B23.1, or Flag-B23ΔA, 
followed by immunoblotting with anti-Histone H3 antibody (Fig. 5B).  B23ΔC did not bind 
to histone H3, whereas B23ΔA had the histone binding activity as did wild type B23.1.  This 
result is consistent with the result of histone binding assays in vitro (Fig. 4C). 
We investigated whether B23ΔA and B23ΔC inhibit the histone binding activity of 
wild type B23.1 in vivo (Figs. 5C and 5D).  HA-B23.1 was expressed in 293T cells without 
or with Flag-B23ΔA, and immunoprecipitation was carried out using anti-HA antibody, 
followed by immunoblotting with anti-HA, anti-Flag, and anti-histone H3 antibodies.  As 
expected, Flag-B23ΔA did not influence the histone binding activity of HA-B23.1, but rather 
the amount of co-precipitated histone H3 with B23ΔA was slightly increased (Fig. 5C, lanes 8, 
19 
 9, and 10).  Then, Flag-B23.1 was expressed in 293T cells without or with HA-B23ΔC, and 
immunoprecipitation was carried out with anti-Flag antibody, followed by immunoblotting 
with anti-Flag, anti-HA, and anti-histone H3 antibodies (Fig. 5D).  In contrast to 
Flag-B23ΔA, HA-B23ΔC inhibited the histone binding activity of Flag-B23.1 in a 
dose-dependent manner through interacting with Flag-B23.1 (Fig. 5D, lanes 7 and 8).  This 
result indicates that B23ΔC forms a hetero-oligomer with B23.1 and inhibits the histone 
binding activity of B23.1 in vivo. 
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Inhibition of the rRNA gene transcription by B23ΔC  
We have shown that B23ΔC inhibits the histone binding activity of B23.1 in a 
dominant-negative manner.  Therefore, B23ΔC could be a powerful tool to clarify the 
cellular function of B23 as a histone chaperone.  Next, we examined the effect of B23ΔC on 
the rRNA gene transcription.  293T cells expressing HA-B23ΔC were lysed, and HA-B23ΔC 
was immunoprecipitated with anti-HA antibody (Fig. 6A).  Approximately 50% of 
endogenous B23.1 were co-precipitated with HA-B23ΔC under the condition employed here.  
Therefore, it is quite likely that HA-B23ΔC can quench the function of endogenous B23 in 
cells.  In order to examine the effect of HA-B23ΔC on the chromatin binding activity of B23, 
nucleolar ChIP with anti-B23 antibody was carried out using nucleoli purified from 293T 
cells transfected with plasmids encoding HA-B23.1 and HA-B23ΔC.  The association of 
B23 with the rRNA gene promoter region was examined by quantitative PCR using 
immunoprecipitated DNA and a specific primer set (Fig. 6B).  We found that B23 binds to 
the promoter region of the rRNA gene, and over-expression of HA-B23ΔC decreased this 
association by 25%.  Next, we examined the effect of HA-B23ΔC on the chromatin structure 
20 
 of the rRNA gene promoter region.  Binding of transcription factors of the rRNA gene, UBF 
and TBP, was not affected or slightly up-regulated by expression of HA-B23ΔC (Fig. 6C), 
while the amount of histone H3 or acetylated histone H3 associated with the rRNA gene 
increased by expression of HA-B23ΔC (Fig. 6D).  Histone H3 distribution over the rRNA 
gene locus was examined (Fig. 6E, upper panel).  The amount of histone in cells expressing 
B23ΔC was higher than that in mock-treated cells over the rRNA gene locus.  
Over-expression of B23ΔC increased the histone density of the coding region of 18S rRNA 
gene (Fig. 6E, lower panel).  The histone density on the rRNA gene except for the region 
encoding 18S rRNA is 1.3 ~ 1.8 fold higher in cells expressing B23ΔC compared with that of 
mock-treated cells, consisting with the result using siB23 (Fig. 3E), whereas the histone 
density on the region coding 18S rRNA was 2.9 fold higher in cells expressing B23ΔC than 
that in mock-treated cells.  The reason for this discrepancy between the results in Fig. 3E and 
Fig. 6E is presently unclear, but assumed to be due to the difference of cell types used in 
experiments.  The results shown in Fig. 3D and Fig. 6D indicate that the amount ratio of 
acetylated histone H3 to histone H3 on the rRNA gene in HeLa cells was lower than that of 
293T cells.  In other words, this could be interpreted as that the ratio of the number of fully 
active rRNA genes to the total number of the rRNA genes is higher in 293T cells than that of 
HeLa cells.  Nevertheless, it is suggested that B23 controls the histone density on the rRNA 
gene. 
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Next, we analyzed the transcription activity of Pol I in cells expressing HA-B23ΔC.  
Nuclei were isolated from 293T cells expressing HA-B23ΔC, and run-on assays were carried 
out (Fig. 6F).  Run-on assays demonstrated that the transcription level of the rRNA gene in 
293T cells expressing HA-B23ΔC was lower by 0.6 fold than that of control cells, suggesting 
21 
 that over-expression of HA-B23ΔC down-regulates the activity of Pol I possibly by blocking 
the function of endogenous B23.  Moreover, we examined the effect of B23ΔA on the 
transcription of the rRNA gene, which binds to histones but lacks the histone chaperone 
activity (Fig. 4D).  Quantitative RT-PCR for pre-rRNA demonstrated that the amount of 
pre-rRNA in cells expressing B23ΔA was lower than that of control cells (Fig. 6G).  This 
result may be interpreted as that B23ΔA forms oligomer with endogenous B23.1 and inhibits 
the rRNA transcription as does B23ΔC.  Thus, it is quite possible that B23 controls the 
histone density on the rRNA gene, and thereby regulates the transcription of the rRNA gene as 
a nucleolar histone chaperone. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
We tried to confirm the above notion by complementation experiments.  By 
monitoring the transcription of the rRNA gene, we examined the rescue ability of B23 mutant 
proteins for HeLa cells treated with siRNA specific for B23.1.  After treatment of siB23-C, 
HeLa cells were super-transfected with plasmids encoding various B23 proteins with 
pEF321-T encoding SV40 T antigen in order to amplify the expression level of B23 proteins 
supplied by pCAGGS and/or pCHA, which contain the replication origin of SV40.  siB23-C 
recognizes the 3’UTR of endogenous mRNA of B23.1, and we constructed pCAGGS-based 
plasmids encoding B23 mutant proteins without the siB23-C target sequence.  Therefore, 
siB23-C does not affect the expression of exogenous B23 mutant proteins.  The expression 
level of B23 proteins was detected by immunoblotting using anti-B23 or anti-HA antibodies 
(Fig. 7A).  The amount of 45S pre-rRNA in HeLa cells was examined by quantitative 
RT-PCR using the 5’ETS-specific primer set for the rRNA gene.  The reduction in synthesis 
of 45S pre-rRNA by siB23-C was recovered by the expression of Flag-B23.1 in a 
dose-dependent manner (Fig. 7B, lanes 2-4).  In contrast, Flag-B23ΔA and HA-B23ΔC could 
22 
 not rescue the synthesis of 45S pre-rRNA reduced by siB23-C, but rather B23ΔC decreased 
the synthesis of 45S pre-rRNA (Fig. 7B, lanes 2, and 5-8).  These results indicate that 
Flag-B23.1 promotes the transcription of the rRNA gene, but Flag-B23ΔA and HA-B23ΔC do 
not.  B23ΔA was shown to be capable of binding to histones (Fig. 4C), but it does not have 
the histone chaperone activity (Fig. 4D), indicating that the acidic domain of B23.1 is critical 
for the histone chaperone activity and the promoting activity of the rRNA gene transcription.  
Thus, it is concluded that the histone binding activity of B23 is not sufficient for the rRNA 
gene transcription promotion, and not only the histone binding activity but also the histone 
chaperone activity is required (27). 
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Inhibition of cell growth by over-expression of B23ΔC 
 We have shown the positive correlation between the B23 histone chaperone activity 
and the rRNA gene transcription.  Next, we investigated the function of B23 in the cell 
growth.  To this end, we took advantage of B23ΔC, a dominant-negative type mutant for the 
histone chaperone activity of B23.  293T cells were co-transfected with plasmids encoding 
B23ΔC and EGFP.  The number of EGFP-positive cells, thus quite possibly B23ΔC-positive 
cells, was counted every 24 hrs post transfection (Fig. 8A).  The cell growth of 293T cells 
expressing B23ΔC seemed to be stopped.  The cell growth rate was decreased in proportion 
to the expression level of B23ΔC (Fig. 8B).  In cells expressing B23ΔC3, the rRNA 
synthesis was inhibited (Fig. 6).  Moreover, KD of the expression of B23.1 by siB23-C 
decreased the cell growth rate (data not shown).  Thus, it is possible that B23ΔC suppresses 
the synthesis of the rRNA gene, and thereby affects the cell growth rate. 
Alternatively, B23ΔC may affect the cell growth through other pathway(s), since 
23 
 B23 is a multifunctional protein.  We examined the cell cycle profile of cells expressing 
B23ΔC.  It is suspected that the growth inhibition by expression of B23ΔC is due to 
apoptosis.  However, the population of apoptotic cells was not increased by expression of 
B23ΔC (Fig. 8C, inlet table).  As shown in Fig. 8C, G2/M population was slightly increased 
by expression of B23ΔC.  This result may be consistent with the observation with B23-/- 
MEFs (17, 31).  Tetraploid cells contain 4n DNA as do cells in G2/M phase.  On this line, 
the p53 pathway involved in centrosome duplication that is essential for ploidy maintenance 
is one of the candidates for the cell growth defect by expressing B23ΔC.  It was reported that 
B23 regulates the stability and the transcriptional activity of p53 directly or indirectly (5, 29).  
To exclude the possibility that B23ΔC inhibited the cell growth through affecting the p53 
pathway, we examined the effect of over-expression of B23ΔC on the cell growth rate of 
p53-/- MEF (mouse embryonic fibroblast).  As shown in Fig. 8D, the cell growth rate of 
p53-/- MEF was similarly decreased by over-expression of B23ΔC.  The effect of B23ΔC on 
the cell growth of p53-/- MEF seems lower than that of 293T cells.  This could be due to the 
fact that a pCAGGS-based expression vector is amplified in 293T cells expressing SV40 T 
antigen but not in p53-/- MEF, so that the expression level of B23ΔC is higher in 293T cells 
than p53-/- MEF.  Thus, the cell growth inhibition activity of B23ΔC is independent of the 
p53 pathway.  From these results, we concluded that over-expression of B23ΔC leads to the 
growth inhibition most possibly through down-regulation of the rRNA gene transcription. 
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In this study, we examined the function of B23 as a nucleolar histone chaperone.  
Here, we have confirmed that the expression level of B23 is correlated with the rate of the 
rRNA gene transcription (Fig. 1).  KD of B23 by siRNA decreased the transcription rate of 
rRNA gene (Fig. 2).  It was shown using nucleolar ChIP assays that B23 is associated with 
the rRNA gene in cells (Fig. 3).  To test the histone chaperone activity of B23 in cells, we 
constructed B23ΔC, a dominant-negative mutant, which inhibited the histone binding activity 
of B23.1 (Figs. 4 and 5).  B23ΔC over-expressed in 293T cells bound to endogenous B23.1 
and decreased the transcription rate of the rRNA gene in vivo (Fig. 6).  Expression of 
exogenous B23.1 but neither B23ΔA nor B23ΔC could rescue the rRNA synthesis reduced by 
siRNA (Fig. 7).  Finally, over-expression of B23ΔC results in inhibition of the cell growth 
(Fig. 8).  These results altogether suggest that B23 regulates the transcription of rRNA gene 
as a nucleolar histone chaperone and thus affects the cell growth rate. 
The inhibitory effect of siB23-C (Fig. 2D) and B23ΔC (Fig. 6F and G) on the rRNA 
transcription seemed incomplete.  However, these changes in the transcription rate of the 
rRNA genes are ranged in almost the same level as the difference between the rRNA synthesis 
levels of cells maintained in 10% and 1% serum (Fig. 1C and D).  The tandem rRNA gene 
repeats exist in two distinct types of chromatin, an ‘open’ one permissive for transcription and 
a ‘closed’ one under the transcriptionally repressive state.  It is reported that the number of 
the rRNA genes existing as open chromatin is independent of the cell growth rate (6).  Based 
on these, it is possible that B23 may not be involved in remodeling of chromatin around the 
rRNA gene between open and closed states.  Then, we would consider the possibility that 
25 
 B23 is required for maintenance of an open chromatin.  The results in this study show that 
the rRNA gene transcription is proportional to the amount of B23.  B23 remodels the 
chromatin structure and stimulates the transcription from chromatin template (57, unpublished 
results, and see below).  We assume that the amount of B23 is a switch for the rRNA 
transcription fluctuation in response to a variety of continuous stresses/stimuli from outside 
and in side of cells. 
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In eukaryotic cells, the chromatin structure plays an important role in regulation of 
gene expression.  In the nucleolus, it was shown that NoRC, a nucleolar ATP-dependent 
chromatin remodeling complex, recruits histone deacetylase and DNA methyltransferase 
activities on the rRNA genes to induce formation of heterochromatin on the rRNA genes (38, 
50).  B23 has been shown to be acetylated by p300 and stimulate transcription preferentially 
from a chromatin template containing acetylated histones, although the stimulation by 
acetylated B23 occurs in transcription assay using RNA polymerase II in the presence of 
transactivator Gal4-VP16 in vitro (57).  This observation suggests that B23 facilitates 
disassembly of histones over the rRNA gene in combination with p300 to stimulate the 
transcription of the rRNA gene.  Non-acetylable B23 mutants would be powerful tools for 
further analysis of the coordination mechanism between B23 and p300 on the rRNA gene 
transcription.  In addition, B23 was shown to interact with nucleolin, which is one of 
nucleolar histone chaperones and enhances the activity of the chromatin remodeling 
machineries, SWI/SNF and ACF (1, 34, 48).  B23 and nucleolin as nucleolar histone 
chaperones may regulate the transcription of the rRNA gene through the structural change of 
chromatin with ATP-dependent chromatin remodelers and histone modification enzymes in 
coordinated manner. 
26 
 Nucleoplasmin 3 (NPM3) was identified as a B23 binding protein from mouse liver 
cDNA library using yeast two hybrid system (23).  NPM3 shows the significant structural 
similarity to B23ΔC and is found to interact with endogenous B23.  Over-expression of 
NPM3 decreased the rate of pre-rRNA synthesis and processing.  It is possible that NPM3 
also functions as an inhibitor for the histone binding activity of endogenous B23 as does 
B23ΔC.  We have also observed retardation of rRNA processing by overexpression of 
B23ΔC (data not shown).  Since B23.2 lacking the C-terminal RNA binding domain was 
found to form an oligomer with B23.1 and inhibit the RNA binding activity of B23.1 (46), it 
is likely that B23ΔC also inhibits not only the histone chaperone activity but also the RNA 
binding activity of B23.1.  The RNA binding activity of B23.1 could be important to target 
B23.1 to pre-rRNA to be processed.  This could be one of the reasons why over-expression 
of B23ΔC and NPM3 inhibits the pre-rRNA processing. 
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From the observation that B23, NPM3, and nucleolin are involved in pre-rRNA 
synthesis and processing (1, 15, 23, 48, 51), it is likely that the rRNA gene transcription and 
pre-rRNA processing are coupled and co-regulated.  This idea is supported by the result that 
B23 associates with not only the promoter region but also the region encoding 5.8S rRNA 
next to ITS2 cleaved by B23 (Fig. 3B).  In yeast cells, Pol I transcription and pre-rRNA 
processing were shown to be linked by pre-rRNA processing factors (13, 16, 52) and the 
complex containing Pol I drives both transcription and pre-rRNA modifications in vitro (11).  
In mammalian cells, B23 could be one of the molecules to link between the rRNA gene 
transcription and pre-rRNA processing. 
We demonstrated that B23ΔC drastically decreased the cell proliferation rate of 
293T cells (Fig. 8A).  B23+/-, B23hy/hy (homozygous hypomorphic mutants) and B23-/- MEFs 
27 
 show the decreased cell proliferation rate compared with wild type MEF (17).  It was 
previously reported that B23 binds to p53 directly and enhances its stability and the 
transcriptional activity of p53, so that over-expression of B23.1 induces inhibition of MEF 
proliferation (5).  B23 interacts with ARF and Mdm2, those of which are involved in cell 
cycle regulation in concert with p53 (3, 29, 30).  We had suspected that B23ΔC inhibits the 
cell proliferation through the p53 pathway.  However, this possibility was ruled out by 
experiments using p53-/- MEF (Fig. 8D).  This is supported by the report that a deletion 
mutant of B23 similar to B23ΔC does not bind to p53 in vitro, and the expression of B23.1 
increases the proliferation rate of p53-/- MEF slightly (5). 
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Figure 1  Relationship between the cell growth and the level of rRNA gene transcription. 
  (A) Expression level of B23.  293T cells were maintained in DMEM in the 
presence of 1% (lanes 1 and 3) or 10% (lanes 2 and 4) of FBS for 24 h (lanes 1 and 2) or 48 h 
(lanes 3 and 4), and then pulse-labeled with [35S]methionine for 1 h.  [35S]-labeled B23 
proteins were immunopurified using anti-B23 antibody and analyzed by electrophoresis on a 
10% SDS-PAGE followed by autoradiography.  As a loading control, 10% of input lysates 
was separated on a 10% SDS-PAGE, and β-actin was detected by immunoblotting.  (B) 
Expression level of nucleolus-related genes.  293T cells were maintained in DMEM in the 
presence of 1% (lanes 1 and 3) or 10% (lanes 2 and 4) of FBS for 24 h (lanes 1 and 2) or 48 h 
(lanes 3 and 4).  Expression level of each indicated proteins were analyzed by 
immunoblotting.  (C) Transcription rate of the rRNA gene.  293T cells were maintained in 
DMEM in the presence of 1% or 10% of FBS for 72 h.  The expression level of the rRNA 
gene was detected by run-on assays using [α-32P]GTP.  Labeled rRNA was used as a probe 
for hybridization to membrane-blotted plasmid DNAs containing the rRNA gene 
(pUC-119-HurDNA) and pUC119 as a control.  Results are represented as mean values ± SD 
from three independent experiments.  (D) Accumulation level of pre-rRNA.  293T cells 
were maintained in DMEM in the presence of 1% or 10% of FBS for 72 h.  The expression 
level of pre-rRNA and β-actin mRNA as a loading control was detected by quantitative 
RT-PCR (left and middle panels).  The amount of pre-rRNA was normalized with that of 
β-actin mRNA in the right panel.  Results are represented as mean values ± SD from three 
independent experiments. 
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Figure 2  Repression of the rRNA gene transcription by siB23 
(A) Expression level of B23.1.  In the left panel, immunoblotting was performed 
using lysates prepared from HeLa cells treated with 40 pmol of control siRNA (lane 1) and 
siB23-A (lane 2), B (lane 3), and C (lane 4) (siRNA for B23.1).  The mRNA level of B23.1 
was also decreased by transfection of siB23-C compared with control siRNA (Fig. S2 in 
supplemental material).  (B) Expression level of nucleolus-related proteins.  The expression 
level of indicated each protein was determined by immunoblotting using HeLa cells treated 
with control siRNA and siB23-C.  (C) Expression of B23 in nucleoli.  Cellular B23 was 
stained by indirect immunofluorescence method using anti-B23 antibody in HeLa cells treated 
with control siRNA or siB23-C.  Nuclei were visualized with DAPI.  Arrows indicate the 
position of nucleoli.  (D) Quantitative determination of pre-rRNA by RT-PCR.  RNA 
isolated from HeLa cells treated with control siRNA or siB23-C was examined by RT-PCR 
using 5’ ETS-specific primers for pre-rRNA (left panel) and primers for β-actin (middle 
panel).  The amount of pre-rRNA was normalized with that of β-actin mRNA (right panel).  
Results are represented as mean values ± SD from three independent experiments. 
 
Figure 3  Association of B23 with the chromatin around the rRNA gene 
(A) Nucleolar ChIP analysis using quantitative PCR (Q-PCR).  DNA was extracted 
from soluble nucleolar chromatin immunoprecipitated using anti-Flag, anti-B23, and anti-TBP 
antibodies.  Q-PCR was performed using promoter-specific primers for the rRNA gene and 
ChIPed DNA as templates.  Results are represented as mean values ± SD from three 
independent experiments.  (B) ChIP analysis using Q-PCR through whole rRNA gene unit.  
39 
 The structure of the human rRNA gene unit is shown under the graph.  Grey boxes indicate 
18S, 5.8S, and 28S rRNA encoding sequences.  Horizontal arrow indicates the transcription 
initiation site (+1) of the rRNA gene transcribed by Pol I.  DNA was extracted from soluble 
chromatin immunoprecipitated using anti-Flag and anti-B23 antibodies.  Q-PCR was 
performed using ChIPed DNA as templates and primer sets indicated in Table 1.   Results 
are represented as mean values ± SD from three independent experiments.  (C) ChIP 
analysis using Q-PCR.  293T cells were maintained in DMEM in the presence of 1% or 10% 
of FBS for 72 h.  DNA was extracted from chromatin that was immunoprecipitated using 
anti-Flag, and anti-B23 antibodies.  Q-PCR was performed using promoter specific primers 
for the rRNA gene and ChIPed DNA as templates.  Results are represented as mean values ± 
SD from three independent experiments.  (D) Histone density on the rRNA gene promoter.  
Soluble chromatin fraction from HeLa cells treated with control siRNA or siB23-C was 
examined by ChIP analyses using anti-Flag, anti-B23, anti-UBF, anti-TBP, anti-acetylated 
histone H3, and anti-histone H3 antibodies.  Q-PCR was performed using promoter-specific 
primers for the rRNA gene and ChIPed DNA as templates.  Results are represented as mean 
values ± SD from three independent experiments.  (E) Histone distribution over the rRNA 
gene.  At the same time in (D), Q-PCR was carried out over the rRNA gene (upper panel).  
The ratio of the histone density over the rRNA gene in cells treated with siB23-C relative to 
that in cells treated with control siRNA is plotted (middle panel).  Results are represented as 
mean values ± SD from three independent experiments. 
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Figure 4  Inhibition of the histone binding activity of B23.1 by B23ΔC in vitro 
 (A) Schematic representation of the structure of B23.1, B23ΔA, and B23ΔC.  Grey, 
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 black, and striped boxes indicate oligomeric domain, acidic domain, and RNA binding 
domain, respectively.  (B) Purification of recombinant proteins.  Recombinant His-B23.1, 
His-B23ΔA, and His-B23ΔC were purified, and proteins (400 ng) were separated with a 
12.5% SDS-PAGE followed by CBB staining.  (C) Histone binding activity of B23 mutants.  
Recombinant B23 proteins (500 ng) were mixed with 300 ng core histones purified from 
HeLa cells.  Immunoprecipitation was carried out using an anti-His antibody.  Precipitated 
proteins were analyzed by a 12.5% SDS-PAGE followed by immunoblotting with anti-His 
and anti-histone H3 (α-H3) antibodies.  (D) Nucleosome assembly activity of B23 mutants.  
The nucleosome assembly activity of B23 mutants was examined by supercoiling assay.  
Core histones (200 ng) preincubated without (lane 1) or with His-B23.1 (167 ng for lane 2, 
500 ng for lane 3, and 1500 ng for lane 4), His-B23ΔA (142 ng for lane 5, 425 ng for lane 6, 
and 1275 ng for lane 7), and His-B23ΔC (66.8 ng for lane 8, 200 ng for lane 9, and 600 ng for 
lane 10), were mixed with closed circular DNA relaxed by topoisomerase I and further 
incubated.  The amounts of B23 mutant proteins were adjusted according to their sizes so as 
to be added at the same molecular numbers.  The DNA was purified and separated by 
electrophoresis on a 1% agarose gel, and visualized by staining with ethidium bromide.  
Positions of relaxed (R), supercoiled (S), or nicked (N) circular plasmid DNA are indicated.  
(E) Inhibition of the histone binding activity of B23.1 by B23ΔC.  His-B23.1 (200 ng) was 
mixed without (lane 2) or with 200 ng (lane 3) or 400 ng (lane 4) of B23ΔC and subjected to 
the denature-renature protocol.  Renatured B23 complexes were mixed with 300 ng core 
histones purified from HeLa cells.  Immunoprecipitation of His-B23.1 was carried out using 
an anti-B23 antibody that can not recognize B23ΔC protein.  Precipitated proteins were 
analyzed by a 12.5% SDS-PAGE followed by silver staining (left panel) and immunoblotting 
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 (IB) with an anti-His antibody (right panel).  H and L indicate heavy and light chains of 
immunoglobulin, respectively.  The position of core histones are indicated beside the left 
panel. 
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Figure 5  Inhibition of the histone binding activity of B23.1 by B23ΔC in vivo 
 (A) Expression of B23 proteins in 293T cells.  Immunoblotting was carried out 
using lysate prepared from 293T cells transfected with each plasmids indicated above each 
lane.  Left and right panels indicate immunoblotting by anti-HA and anti-Flag antibodies, 
respectively.  (B) Histone binding activity of B23 mutants.  Immunoprecipitation (IP) with 
anti-HA and anti-Flag antibodies were performed using lysate of 293T cells transfected with 
plasmids expressing B23 proteins.  Immunoprecipitated proteins were analyzed by 
immunoblotting using anti-Flag, anti-HA, and anti-histone H3 antibodies, respectively.  (C) 
No effect of B23ΔA on the histone binding activity of B23.1.  Lysates of 293T cells (24 h 
post transfection) transfected with pCHA-B23.1 (160 ng for lanes 2-5, and 7-10) and 
pCAGGS-Flag-B23ΔA (160 ng for lanes 3 and 8, 480 ng for lanes 4 and 9, and 1440 ng for 
lanes 5 and 10), were subjected to immunoprecipitation with an anti-HA antibody.  
Immunoprecipitated proteins were analyzed by immunoblotting using anti-Flag, anti-HA, and 
anti-histone H3 antibodies, respectively.  (D) Inhibition of the histone binding activity of 
B23.1 by B23ΔC in vivo.  Lysates of 293T cells (24 h post transfection) transfected with 
pcDNA3-Flag-B23.1 (100 ng for lanes 2-4, and 6-8) and pCHA-B23ΔC  (300 ng for lanes 3 
and 7, and 1400 ng for lanes 4 and 8), were subjected to immunoprecipitation with anti-Flag 
antibody.  Immunoprecipitated proteins were analyzed by immunoblotting using anti-Flag, 
anti-HA, and anti-histone H3 antibodies, respectively. 
42 
  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
Figure 6  Inhibition of the rRNA gene transcription by B23ΔC 
(A) Interaction of B23ΔC with endogenous B23.  293T cells were transiently 
transfected with pCHA (control) and pCHA-B23ΔC, and cultured for 72 h post transfection.  
Lysates prepared from 293T cells were used for immunoprecipitation with anti-HA antibody 
(lanes 3, 4, 7, and 8).  Immunoprecipitates (P) and flow-through fraction (F) were resolved 
by a 12.5% SDS-PAGE, transferred to a membrane, and probed with anti-B23 (upper panel) 
and anti-HA (lower panel) antibodies.  (B) Inhibition of association of B23 with the rRNA 
gene by B23ΔC.  293T cells were co-transfected with pBabe-puro and indicated plasmids 
(pCHA, pCHA-B23.1, and pCHA-B23ΔC), and 0.5 μg/ml puromycin was added after 24 h 
post transfection.  After puromycin selection for 30 h, 293T cells were maintained in fresh 
medium for 18 h.  Nucleolar ChIP was carried out using anti-B23 and anti-Flag antibodies.  
Quantitative PCR was performed with primers around the promoter region of the rRNA gene.  
Results are represented as mean values ± SD from three independent experiments.  A paired 
Student’s t-test gave P=0.02 between pCHA- and pCHA-B23ΔC-transfected cells.  (C) 
Association of transcription factors on the rRNA gene promoter.  ChIP was carried out using 
anti-UBF and anti-TBP antibodies and lysates prepared for mock-treated cells or cells 
expressing B23ΔC.  Q-PCR was performed with primers around the promoter region of the 
rRNA gene.  Results are represented as mean values ± SD from three independent 
experiments.  (D) Histone density on the rRNA gene promoter.  ChIP was carried out using 
anti-B23, anti-histone H3, and anti-acetylated histone H3 (AcH3) antibodies in the presence 
or absence of B23ΔC.  Q-PCR was performed with primers around the promoter region of 
the rRNA gene.  Results are represented as mean values ± SD from three independent 
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 experiments.  (E) Histone distribution over the rRNA gene.  ChIP was performed with 
anti-histone H3 antibody using cells expressing HA-B23ΔC or mock-treated cells.  Amount 
of ChIPed DNA was determined by Q-PCR using primer sets over the rRNA gene (upper 
panel).  The ratio of the histone density over the rRNA gene in cells expressing B23ΔC 
relative to that in mock-treated cells is plotted (middle panel).  Results are represented as 
mean values ± SD from three independent experiments.  (F) Inhibition of the rRNA gene 
transcription by B23ΔC.  293T cells were transiently transfected with pCHA (control) and 
pCHA-B23ΔC, and cultured for 72 h post transfection.  Nuclei isolated from these 293T 
cells were used for run-on transcription assays.  Radiolabeled nuclear RNA was isolated and 
hybridized with 1 μg of pUC119 (control) and pUC119-HurDNA (rRNA) on a membrane.  
This assay was done in triplicate, and a typical pattern is shown.  The right panel shows a 
densitometry quantitation of the hybridization signals.  Results are represented as mean 
values ± SD from three independent experiments.  (G) Inhibition of the rRNA gene 
transcription by B23ΔA.  293T cells were co-transfected with pBabe-puro and either one of 
indicated plasmids (pCHA, pCHA-B23ΔC, and pCHA-B23ΔA), and 0.5 μg/ml puromycin 
was added after 24 h post transfection.  After puromycin selection for 30 h, 293T cells were 
maintained in fresh medium for 18 h.  RNA isolated from 293T cells was examined by 
RT-PCR using 5’ ETS-specific primers for pre-rRNA (left panel) and primers for β-actin 
mRNA (middle panel).  Results are represented as mean values ± SD from three independent 
experiments. 
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Figure 7  Involvement of acidic domains of B23 in the rRNA gene transcription 
 (A) Expression of B23 proteins in HeLa cells transfected with siB23.  HeLa cells 
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 were transfected with 40 pmol of control siRNA (lane 1) and 40 pmol of siB23-C (lanes 2-8).  
At 12 h after siRNAs transfection, HeLa cells were super-transfected with 
pCAGGS-Flag-B23.1 (180 ng for lane 3, and 360 ng for lane 4), pCAGGS-Flag B23ΔA (180 
ng for lane 5, and 360 ng for lane 6), pCHA-B23ΔC (180 ng for lane 7, and 360 ng for lane 8), 
and pEF321-T (40 ng for lanes 1-8) encoding SV40 T antigen for amplification of transfected 
plasmid.  After 72 h post siRNAs transfection, lysate of 2.5 x 103 cells were analyzed by 
immunoblotting using anti-B23, anti-HA, and anti-β-actin antibodies, respectively.  (B) 
Quantitative determination of pre-rRNA by Q-PCR.  At the same time with (A), total RNA 
extracted from HeLa cells were examined by RT-PCR using 5’ETS-specific primers for the 
rRNA gene.  The amount of pre-rRNA was normalized with that of β-actin mRNA.  Results 
are represented as mean values ± SD from three independent experiments. 
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Figure 8  Inhibition of cell proliferation by B23ΔC 
 (A) Proliferation inhibition of 293T cells by expression of B23ΔC.  293T cells 
were co-transfected with 1400 ng of pCHA and 200 ng of pEGFP-N1 or with 1400 ng of 
pCHA- B23ΔCand 200 ng of pEGFP-N1.  The number of EGFP-positive cells was counted 
every 24 hrs as a function of culture time.  Results are represented as mean values ± SD from 
three independent experiments.  (B) B23 dose-dependent inhibition of the cell proliferation 
rate.  The number of EGFP-positive cells was counted at 72 h after transfection of 200 ng of 
pEGFP-N1 with pCHA-B23ΔC (350 ng (lane 2), 700 ng (lane 3), and 1400 ng (lane 4)), and 
pCHA (1400 ng (lane 1), 700 ng (lane 2), and 350 ng (lane 3)).  Results are represented as 
mean values ± SD from three independent experiments.  (C) Cell cycle population of cells 
expressing B23ΔC.  293T cells were co-transfected with 1400 ng of pCHA and 200 ng of 
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pEGFP-N1 or with 1400 ng of pCHA-B23ΔC and 200 ng of pEGFP-N1, and then incubated 
for 72 h.  Cell population of 293T cells expressing EGFP was determined by FACS analysis 
(left panel).  Sub-G1 fraction was quantitatively determined as a population of apoptotic 
cells and shown in the right inlet table.  (D) p53-independent effect of B23ΔC on the cell 
proliferation.  The number of EGFP-positive p53-/- MEF cells was counted at 72 h post 
transfection of pEGFP-N1 (125 ng) with pCHA-B23.1 (875 ng) or pCHA-B23ΔC (875 ng).  
Results are represented as mean values ± SD from three independent experiments. 
 
